| Quarterly Financials | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 62 | 68 | 71 | 77 | 73 | 88 | 65 | 109 | 88 | 108 | 97 | 117 | 95 | 108 | 116 | 128 |
| Expenses | 30 | 33 | 32 | 38 | 38 | 41 | 39 | 76 | 66 | 74 | 66 | 76 | 67 | 75 | 78 | 87 |
| EBITDA | 32 | 36 | 39 | 40 | 36 | 47 | 26 | 34 | 22 | 34 | 31 | 41 | 28 | 33 | 39 | 41 |
| Operating Profit % | 51 % | 52 % | 53 % | 50 % | 47 % | 52 % | 37 % | 29 % | 22 % | 26 % | 31 % | 33 % | 27 % | 27 % | 28 % | 28 % |
| Depreciation | 4 | 3 | 5 | 5 | 5 | 7 | 10 | 12 | 11 | 14 | 17 | 20 | 20 | 23 | 25 | 29 |
| Interest | 1 | 1 | 1 | 2 | 1 | 0 | 3 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 6 | 6 |
| Profit Before Tax | 28 | 32 | 33 | 34 | 29 | 39 | 14 | 17 | 6 | 15 | 8 | 16 | 3 | 6 | 8 | 6 |
| Tax | 7 | 8 | 9 | 9 | 7 | 10 | 4 | 7 | 2 | 5 | 3 | 5 | 1 | 2 | 3 | 2 |
| Net Profit | 21 | 24 | 25 | 25 | 22 | 30 | 10 | 10 | 4 | 10 | 5 | 10 | 2 | 3 | 5 | 4 |
| EPS in ₹ | 4.13 | 4.59 | 4.88 | 4.89 | 4.14 | 5.69 | 1.87 | 1.94 | 0.75 | 1.93 | 0.99 | 1.92 | 0.34 | 0.62 | 0.95 | 0.79 |
Tarsons Products
Tarsons Products
215.66
+8.69
(4.20%)
Market Cap
1,147.45 Cr
PE Ratio
76.78
Volume
71,812.00
Day High - Low
216.79 - 205.22
52W High-Low
402.85 - 164.45
Key Fundamentals
Market Cap
1,147.45 Cr
EPS
2.69
PE Ratio
76.78
PB Ratio
1.73
Book Value
119.29
EBITDA
116.80
Dividend Yield
0.00 %
Industry
Healthcare Sector
Medical Equipment Return on Equity
4.72
Debt to Equity
0.49
Actual
Company News
View All News
Tarsons Products will attend a virtual investor conference hosted by Choice Broking on June 11, 2026. The meeting will cover publicly available information.
Tarsons Products invested EUR 552,000 in its Singapore subsidiary on June 03, 2026. The funds will repay bank loans and meet corporate needs.
Tarsons Products has scheduled an Investor/Analyst Conference Call on May 25, 2026, at 12:00 Noon IST to discuss Q4 & FY26 financial and operational performance.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,458.80 | #1 14,786.32 | 43.75 | #1 1,875.26 | 6.61 | #1 326 | -29.19 | 51.08 | |
224.45 | 1,233.63 | 42.37 | 271.50 | 12.00 | 22 | #1 134.88 | 53.03 | |
215.66 | #3 1,147.45 | #9 76.78 | #2 422.51 | #9 3.45 | #7 16 | #5 -58.82 | 54.00 | |
455.55 | 806.08 | 27.59 | 292.67 | 56.84 | 30 | - | 36.01 | |
399.90 | 693.30 | 72.94 | 278.87 | 10.97 | 10 | -68.29 | 43.71 | |
145.02 | 644.63 | #1 17.16 | 410.77 | 22.29 | 36 | 46.36 | 37.30 | |
370.00 | 482.39 | 25.84 | 231.81 | #1 107.34 | 19 | - | 50.61 | |
368.00 | 441.71 | 22.56 | 71.81 | 7.02 | 21 | 13.73 | 34.25 | |
157.95 | 300.74 | 59.13 | 54.75 | -59.83 | 5 | - | 37.08 | |
231.80 | 221.18 | 104.79 | 146.96 | 20.36 | 3 | -344.00 | 33.92 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
3.45 %
Net Income Growth
-47.08 %
Cash Flow Change
11.23 %
ROE
-32.18 %
ROCE
-23.98 %
EBITDA Margin (Avg.)
-15.70 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2021 | 2022 | 2024 | 2025 | 2026 |
| Total Assets | 296 | 544 | 972 | 1,080 | 1,186 |
| Fixed Assets | 120 | 189 | 336 | 536 | 859 |
| Current Assets | 113 | 245 | 235 | 243 | 266 |
| Capital Work in Progress | 22 | 32 | 267 | 233 | 159 |
| Investments | 0 | 0 | 0 | 0 | 130 |
| Other Assets | 153 | 323 | 369 | 311 | 0 |
| Total Equity & Liabilities | 296 | 544 | 972 | 1,080 | 1,186 |
| Current Liabilities | 42 | 35 | 213 | 176 | 264 |
| Non Current Liabilities | 10 | 20 | 146 | 274 | 287 |
| Total Equity | 244 | 490 | 613 | 630 | 635 |
| Reserve & Surplus | 244 | 479 | 602 | 620 | 624 |
| Share Capital | 0 | 11 | 11 | 11 | 11 |
Cash Flow
| Cash Flow | 2021 | 2022 | 2024 | 2025 |
| Net Cash Flow | -23 | 75 | -47 | 8 |
| Investing Activities | -64 | -138 | -285 | -145 |
| Operating Activities | 68 | 84 | 103 | 114 |
| Financing Activities | -27 | 130 | 136 | 39 |
Share Holding
| % Holding | Aug 2021 | Nov 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 50.99 % | 47.30 % | 47.30 % | 47.31 % | 47.31 % | 47.31 % | 47.31 % | 47.31 % | 47.31 % | 47.31 % | 47.31 % | 47.31 % | 47.31 % | 47.31 % | 47.31 % | 47.31 % | 47.31 % | 47.31 % | 47.30 % | 47.30 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 8.16 % | 7.95 % | 8.04 % | 7.51 % | 9.52 % | 9.14 % | 5.82 % | 2.47 % | 0.87 % |
| DIIs | 0.00 % | 6.92 % | 6.03 % | 7.66 % | 7.39 % | 8.13 % | 8.52 % | 8.45 % | 7.38 % | 3.16 % | 2.15 % | 0.18 % | 0.12 % | 0.21 % | 0.50 % | 0.29 % | 0.04 % | 0.08 % | 0.00 % | 0.19 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 13.55 % | 11.50 % | 10.28 % | 9.94 % | 9.19 % | 9.56 % | 10.00 % | 11.35 % | 11.64 % | 12.77 % | 13.44 % | 13.53 % | 13.06 % | 15.37 % | 15.30 % | 15.42 % | 17.14 % | 20.33 % | 21.54 % |
| Others | 49.01 % | 32.23 % | 35.17 % | 34.75 % | 35.36 % | 35.37 % | 34.62 % | 34.25 % | 33.96 % | 37.90 % | 37.78 % | 30.92 % | 31.10 % | 31.39 % | 29.31 % | 27.58 % | 28.09 % | 29.65 % | 29.89 % | 30.10 % |
| No of Share Holders | 8 | 61 | 1,59,891 | 1,25,714 | 1,12,227 | 1,07,011 | 1,07,945 | 1,05,304 | 1,07,440 | 1,08,236 | 1,07,564 | 1,02,866 | 1,05,330 | 99,586 | 96,927 | 93,417 | 90,891 | 88,966 | 87,336 | 84,093 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.66 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 20 Sept 2024 |  Dividend | ₹ 2.00 /share | 20 Sept 2024 | 418.95 | 468.70 |
| 27 Sept 2024 |  Annual General Meeting | NA | 27 Sept 2024 | 465.20 | 452.15 |
| 07 Nov 2024 |  Quarterly Result Announcement | NA | 07 Nov 2024 | 406.65 | 419.00 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 364.55 | 329.95 |
| 28 May 2025 | Quarterly Result Announcement | NA | 28 May 2025 | 386.30 | 431.20 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 371.20 | 373.10 |
| 22 Sept 2025 | Annual General Meeting | NA | 22 Sept 2025 | 373.10 | 309.15 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 289.05 | 268.10 |
| 06 Feb 2026 | Quarterly Result Announcement | NA | 06 Feb 2026 | 195.16 | 206.34 |
| 22 May 2026 | Quarterly Result Announcement | NA | 22 May 2026 | 207.55 | 210.20 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation3 days ago
3 days agoIntimation Under Regulation 30 Of SEBI LODR Regulations 2015 Regarding Equity Investment.6 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript8 days ago
8 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 23, 2026
May 23, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 23, 2026
May 23, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 22, 2026
May 22, 2026Audited (Standalone And Consolidated) Financial Results For The Quarter And Financial Year Ended March 31 2026.May 22, 2026
May 22, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday May 22 2026May 22, 2026
May 22, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 19, 2026
May 19, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 18, 2026
May 18, 2026Board Meeting Intimation for Considering And Approving The Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended March 31 2026May 18, 2026
May 18, 2026Announcement under Regulation 30 (LODR)-Change in ManagementApr 14, 2026
Apr 14, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2026
Apr 09, 2026Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 09, 2026
Apr 09, 2026Appointment Of Mr. Vinesh Mohan KriplaniApr 08, 2026
Apr 08, 2026Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotApr 08, 2026
Apr 08, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 08, 2026
Apr 08, 2026Announcement under Regulation 30 (LODR)-Credit RatingMar 31, 2026
Mar 31, 2026Closure of Trading WindowMar 24, 2026
Mar 24, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 07, 2026
Mar 07, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 06, 2026
Mar 06, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 11, 2026
Feb 11, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 10, 2026
Feb 10, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 09, 2026
Feb 09, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 06, 2026
Feb 06, 2026Announcement Of Equity Infusion In Our Wholly Owned Subsidiary Based In SingaporeFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Resignation of DirectorFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Change in ManagementFeb 06, 2026
Feb 06, 2026Results For The Quarter And Nine Months Ended December 31 2025.Feb 06, 2026
Feb 06, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday February 06 2026Feb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 30, 2026
Jan 30, 2026Board Meeting Intimation for The Quarter And Nine Months Ended December 31 2025Jan 30, 2026
Jan 30, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2026
Jan 08, 2026Closure of Trading WindowDec 23, 2025
Dec 23, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Nov 28, 2025
Nov 28, 2025Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Further Investment In Tarsons Life Science Pte. Ltd. A Wholly-Owned Subsidiary Of The Company.Nov 27, 2025
Nov 27, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 19, 2025
Nov 19, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Nov 14, 2025
Nov 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 13, 2025
Nov 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 13, 2025
Nov 13, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 13, 2025
Nov 13, 2025Results For The Quarter And Half Year Ended September 30 2025Nov 12, 2025
Nov 12, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On Wednesday November 12 2025Nov 12, 2025
Nov 12, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2025
Nov 11, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 08, 2025
Nov 08, 2025Board Meeting Intimation for Considering And Approving The Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 2025Nov 04, 2025
Nov 04, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Motilal Oswal BSE 1000 Index Fund Direct-Growth | 0.00% | -46 | 0.00% | 0.00% | |
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.00% | 0 | 0.00% | -0.02% |
Technical Indicators
RSI(14)
Neutral 45.82
ATR(14)
Less Volatile 10.17
STOCH(9,6)
Oversold 10.14
STOCH RSI(14)
Neutral 26.16
MACD(12,26)
Bearish -1.14
ADX(14)
Strong Trend 30.18
UO(9)
Bearish 39.80
ROC(12)
Downtrend And Accelerating -2.70
WillR(14)
Oversold -93.06
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
